SSY Group Gets Various Drug Registration, Production Approvals in China

MT Newswires Live05-21

SSY Group (HKG:2005) has obtained approval from China's National Medical Products Administration for the production and registration of three drugs, according to a Thursday filing with the Hong Kong bourse.

The drugs comprise Emedastine Difumarate Eye Drops for temporary relief from allergic conjunctivitis, Perindopril Arginine Tablets to treat hypertension and congestive heart failure, and Peramivir and Sodium Chloride Injection 100ml to treat influenza A and B.

The approval came as the drugs are regarded as passing the regulator's consistency evaluation.

The pharma firm also obtained approval for the Bumetanide Injection after it was regarded as passing the consistency evaluation. The product is mainly used for the treatment of hypertension and edematous diseases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2637435335?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 20:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2637435335","market":"sh","top_or_hot":-1,"title":"SSY Group Gets Various Drug Registration, Production Approvals in China","media":"MT Newswires Live","content":"<html><body><p> SSY Group (HKG:2005) has obtained approval from China's National Medical Products Administration for the production and registration of three drugs, according to a Thursday filing with the Hong Kong bourse.</p><p>The drugs comprise Emedastine Difumarate Eye Drops for temporary relief from allergic conjunctivitis, Perindopril Arginine Tablets to treat hypertension and congestive heart failure, and Peramivir and Sodium Chloride Injection 100ml to treat influenza A and B.</p><p>The approval came as the drugs are regarded as passing the regulator's consistency evaluation.</p><p>The pharma firm also obtained approval for the Bumetanide Injection after it was regarded as passing the consistency evaluation. The product is mainly used for the treatment of hypertension and edematous diseases.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SSY Group Gets Various Drug Registration, Production Approvals in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSSY Group Gets Various Drug Registration, Production Approvals in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-21 20:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> SSY Group (HKG:2005) has obtained approval from China's National Medical Products Administration for the production and registration of three drugs, according to a Thursday filing with the Hong Kong bourse.</p><p>The drugs comprise Emedastine Difumarate Eye Drops for temporary relief from allergic conjunctivitis, Perindopril Arginine Tablets to treat hypertension and congestive heart failure, and Peramivir and Sodium Chloride Injection 100ml to treat influenza A and B.</p><p>The approval came as the drugs are regarded as passing the regulator's consistency evaluation.</p><p>The pharma firm also obtained approval for the Bumetanide Injection after it was regarded as passing the consistency evaluation. The product is mainly used for the treatment of hypertension and edematous diseases.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SSY","symbol_name":"Sunlink Health Systems Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2637435335","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2637435335","pubTimestamp":1779366349,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SSY Group  has obtained approval from China's National Medical Products Administration for the production and registration of three drugs, according to a Thursday filing with the Hong Kong bourse.The drugs comprise Emedastine Difumarate Eye Drops for temporary relief from allergic conjunctivitis, Perindopril Arginine Tablets to treat hypertension and congestive heart failure, and Peramivir and Sodium Chloride Injection 100ml to treat influenza A and B.The approval came as the drugs are regarded as passing the regulator's consistency evaluation.The pharma firm also obtained approval for the Bumetanide Injection after it was regarded as passing the consistency evaluation. The product is mainly used for the treatment of hypertension and edematous diseases.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SSY":"Sunlink Health Systems Inc","BK4185":"保健护理机构","02005":"石四药集团","BK1191":"制药","LU2460026573.USD":"abrdn SICAV I -  CHINA NEXT GENERATION \"A\" (USD) ACC"},"translate_title":"SSY集团在中国获得多项药品注册和生产批件","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SSY":1.5,"02005":1},"content_text":"SSY Group (HKG:2005) has obtained approval from China's National Medical Products Administration for the production and registration of three drugs, according to a Thursday filing with the Hong Kong bourse.The drugs comprise Emedastine Difumarate Eye Drops for temporary relief from allergic conjunctivitis, Perindopril Arginine Tablets to treat hypertension and congestive heart failure, and Peramivir and Sodium Chloride Injection 100ml to treat influenza A and B.The approval came as the drugs are regarded as passing the regulator's consistency evaluation.The pharma firm also obtained approval for the Bumetanide Injection after it was regarded as passing the consistency evaluation. The product is mainly used for the treatment of hypertension and edematous diseases.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2637435335","isCrawlerRequest":true}